Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRADD | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | KDM5A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | HRASLS | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CLCN3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | AKNA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | SPAG4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CIAPIN1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | RP11-296A16.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | RAB26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PRDX6 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |